Electrophysiological study in chagasics with syncope and conduction disorder
- PMID: 38055450
- PMCID: PMC10691369
- DOI: 10.1590/1806-9282.20230322
Electrophysiological study in chagasics with syncope and conduction disorder
Abstract
Background: Investigation of syncope involves the use of electrophysiological study, particularly in patients with cardiac conduction disorder. There is conflicting evidence about the role of electrophysiological study in patients with Chagas disease.
Objective: The objective of this study was to evaluate the electrophysiological study findings in patients with Chagas disease and bundle branch block and/or divisional block presenting with syncope.
Methods: This is a retrospective study of patients with Chagas disease and cardiac conduction disorder who underwent electrophysiological study from 2017 to 2021 for the investigation of syncope in a tertiary hospital in São Paulo, Brazil. Those with non-interpretable ECG, known coronary artery disease, and/or other cardiomyopathies were excluded. HV interval and electrophysiological study-induced malignant ventricular arrhythmias data were analyzed.
Results: A total of 45 patients (60.2±11.29 years, 57.8% males) were included. The mean HV interval was 58.37 ms±10.68; 22.2% of the studied population presented an HV interval of ≥70 ms; and malignant ventricular arrhythmias were induced in 57.8% patients. The use of beta-blockers and amiodarone (p=0.002 and 0.036, respectively), NYHA functional class≥II (p=0.013), wide QRS (p=0.047), increased HV interval (p=0.02), Rassi score >6.5 (p=0.003), and reduced left ventricular ejection fraction (p=0.031) were associated with increased risk of inducible malignant ventricular arrhythmias.
Conclusion: More than half of the patients with Chagas disease, syncope, and cardiac conduction disorder have inducible malignant ventricular arrhythmias. Prolonged HV interval was observed in only 20% of population. Wide QRS, prolonged HV, reduced ejection fraction, and higher Rassi score were associated with increased risk of malignant ventricular arrhythmias.
Conflict of interest statement
Conflicts of interest: the authors declare there is no conflicts of interest.
Figures
References
-
- Scanavacca MI, Brito FS, Maia I, Hachul D, Gizzi J, Lorga A, et al. [Guidelines for the evaluation and treatment of patients with cardiac arrhythmias] Arq Bras Cardiol. 2002;79(Suppl. 5):1–50. - PubMed
-
- Andrade JP, Marin JA, Neto, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al. [I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy] Arq Bras Cardiol. 2011;97(2 Suppl 3):1–48. - PubMed
-
- Pastore CA, Pinho JA, Pinho C, Samesima N, Pereira HG., Filho Kruse JCL et al. III Brazilian society of cardiology guidelines for the analysis and emission of eletrocardiographic reports. Arq Bras Cardiol. 2016;106(4 Suppl. 1):1–23.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
